Annie Mak

1.4k total citations
19 papers, 826 citations indexed

About

Annie Mak is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Annie Mak has authored 19 papers receiving a total of 826 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 8 papers in Infectious Diseases and 3 papers in Hepatology. Recurrent topics in Annie Mak's work include SARS-CoV-2 and COVID-19 Research (6 papers), Influenza Virus Research Studies (6 papers) and Respiratory viral infections research (5 papers). Annie Mak is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (6 papers), Influenza Virus Research Studies (6 papers) and Respiratory viral infections research (5 papers). Annie Mak collaborates with scholars based in Canada, United States and Japan. Annie Mak's co-authors include Danuta M. Skowronski, Martin Petric, Mel Krajden, Gaston De Serres, Trijntje L. Kwindt, Raymond Tellier, David S. Lawrence, Yan Li, Caroline R. Astell and Jacqueline M. Katz and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and The Journal of Infectious Diseases.

In The Last Decade

Annie Mak

19 papers receiving 790 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annie Mak Canada 11 689 304 232 95 93 19 826
Jillian Bennet Australia 6 622 0.9× 247 0.8× 115 0.5× 37 0.4× 156 1.7× 8 684
Mia Broman Finland 7 508 0.7× 286 0.9× 62 0.3× 46 0.5× 158 1.7× 9 680
Charmaine Gittleson Australia 8 697 1.0× 254 0.8× 106 0.5× 41 0.4× 230 2.5× 8 841
Tiansheng Xie China 14 572 0.8× 323 1.1× 234 1.0× 178 1.9× 98 1.1× 45 864
Kisoon Kim South Korea 16 364 0.5× 398 1.3× 56 0.2× 120 1.3× 107 1.2× 63 774
John Treanor United States 8 790 1.1× 264 0.9× 78 0.3× 29 0.3× 290 3.1× 8 1.0k
François Roman Belgium 17 680 1.0× 385 1.3× 89 0.4× 48 0.5× 367 3.9× 44 1.0k
Mia Brytting Sweden 12 486 0.7× 272 0.9× 174 0.8× 23 0.2× 38 0.4× 22 601
Uzma Bashir Aamir Pakistan 15 382 0.6× 442 1.5× 132 0.6× 39 0.4× 36 0.4× 37 657

Countries citing papers authored by Annie Mak

Since Specialization
Citations

This map shows the geographic impact of Annie Mak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annie Mak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annie Mak more than expected).

Fields of papers citing papers by Annie Mak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annie Mak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annie Mak. The network helps show where Annie Mak may publish in the future.

Co-authorship network of co-authors of Annie Mak

This figure shows the co-authorship network connecting the top 25 collaborators of Annie Mak. A scholar is included among the top collaborators of Annie Mak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annie Mak. Annie Mak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Morshed, Muhammad, Min-Kuang Lee, Darrel Cook, et al.. (2022). British Columbia’s Experience after Implementation of the Treponema pallidum Reverse Algorithm and PCR Detection, 2015 to 2020. Microbiology Spectrum. 10(3). e0068622–e0068622. 5 indexed citations
2.
Sekirov, Inna, Vilte Barakauskas, Janet Simons, et al.. (2021). SARS-CoV-2 serology: Validation of high-throughput chemiluminescent immunoassay (CLIA) platforms and a field study in British Columbia. Journal of Clinical Virology. 142. 104914–104914. 12 indexed citations
3.
Levett, Paul N., et al.. (2021). Evaluation of a high volume antigen test for detection of SARS-CoV-2. Journal of Clinical Virology. 142. 104938–104938. 8 indexed citations
4.
Morshed, Muhammad, Inna Sekirov, Paul N. Levett, et al.. (2021). Comparative Analysis of Capillary vs Venous Blood for Serologic Detection of SARS-CoV-2 Antibodies by RPOC Lateral Flow Tests. Open Forum Infectious Diseases. 8(3). ofab043–ofab043. 7 indexed citations
5.
Sekirov, Inna, Martin Petric, David S. Lawrence, et al.. (2021). Performance comparison of micro-neutralization assays based on surrogate SARS-CoV-2 and WT SARS-CoV-2 in assessing virus-neutralizing capacity of anti-SARS-CoV-2 antibodies. Access Microbiology. 3(8). 257–257. 8 indexed citations
6.
Vijh, Rohit, Michael Schwandt, Inna Sekirov, et al.. (2020). Serological survey following SARS-COV-2 outbreaks at long-term care facilities in metro Vancouver, British Columbia: Implications for outbreak management and infection control policies. American Journal of Infection Control. 49(5). 649–652. 9 indexed citations
7.
Krajden, Mel, Darrel Cook, Annie Mak, et al.. (2014). Pooled nucleic acid testing increases the diagnostic yield of acute HIV infections in a high-risk population compared to 3rd and 4th generation HIV enzyme immunoassays. Journal of Clinical Virology. 61(1). 132–137. 25 indexed citations
8.
Isaac‐Renton, Judith L., Natalie Prystajecky, Martin Petric, et al.. (2012). Use of Lean Response to Improve Pandemic Influenza Surge in Public Health Laboratories. Emerging infectious diseases. 18(1). 57–62. 12 indexed citations
9.
Tan, Kennard, et al.. (2011). Mumps Virus Detection During an Outbreak in a Highly Unvaccinated Population in British Columbia. Canadian Journal of Public Health. 102(1). 47–50. 6 indexed citations
10.
Janjua, Naveed Z., Danuta M. Skowronski, Travis Salway, et al.. (2010). Seasonal Influenza Vaccine and Increased Risk of Pandemic A/H1N1‐Related Illness: First Detection of the Association in British Columbia, Canada. Clinical Infectious Diseases. 51(9). 1017–1027. 63 indexed citations
11.
Krajden, Mel, Amanda Yu, Agnes S. Lai, et al.. (2009). GBV‐C/hepatitis G virus infection and non‐Hodgkin lymphoma: a case control study. International Journal of Cancer. 126(12). 2885–2892. 46 indexed citations
12.
Skowronski, Danuta M., Gaston De Serres, Martin Petric, et al.. (2008). Component‐Specific Effectiveness of Trivalent Influenza Vaccine as Monitored through a Sentinel Surveillance Network in Canada, 2006–2007. The Journal of Infectious Diseases. 199(2). 168–179. 89 indexed citations
13.
Skowronski, Danuta M., Trijntje L. Kwindt, Annie Mak, et al.. (2006). Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: Results from the 2005–2006 season of dual A and B vaccine mismatch in Canada. Vaccine. 25(15). 2842–2851. 162 indexed citations
14.
Mak, Annie, Victor Lei, David S. Lawrence, et al.. (2006). Longitudinal Analysis of Genotype Distribution of Influenza A Virus from 2003 to 2005. Journal of Clinical Microbiology. 44(10). 3583–3588. 8 indexed citations
15.
Tweed, Sam, Danuta M. Skowronski, Samara David, et al.. (2004). Human Illness from Avian Influenza H7N3, British Columbia. Emerging infectious diseases. 10(12). 2196–2199. 291 indexed citations
16.
Krajden, Mel, Annie Mak, Gail McNabb, et al.. (2004). Evaluation of the Core Antigen Assay as a Second-Line Supplemental Test for Diagnosis of Active Hepatitis C Virus Infection. Journal of Clinical Microbiology. 42(9). 4054–4059. 22 indexed citations
18.
Modi, V. J., et al.. (1992). Reduction of the side force on pointed forebodies through add-on tipdevices. AIAA Journal. 30(10). 2462–2468. 13 indexed citations
19.
Mak, Annie, et al.. (1990). Reduction of the side force on pointed forebodies through add-on tipdevices. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026